Bing

SEARCH HISTORY

Gilead Sciences GILD-1.05 % paid $125 million for a similar voucher to fight ... is a byproduct of investor expectations of future sales and profits reflected in stock prices. And the higher the latter, the more incentive …
Wall Street Journal · 8/19/2015
Topping the loser board was the Philippines' stock market, which fell 6.96% ... Other names on the list include Gilead Sciences, Inc.(NASDAQ: GILD), CBS Corporation (NYSE: CBS), Lear Corporation (NYSE: LEA) and …
Value Walk · 8/24/2015
Marathon Petroleum Corporation (MPC) declared a dividend of $0.32 per share on common stock, a 28 percent increase from the $0.25 per-share dividend in the first quarter of 2015, after adjusting to reflect the two-for-one stock split that occurred during ...
IT Business Net · 7/29/2015
NEW YORK (MarketWatch) -- Gilead Sciences Inc.'s stock GILD, +3.11% slumped 2.7% in premarket trade, after the biopharmaceutical company issued a warning letter to doctors regarding its hepatitis C treatments Harvoni and Sovaldi. Meanwhile, Wells …
Market Watch · ByTomi Kilgore · 3/23/2015
Krishen Sud’s Sivik Global Healthcare has filed its latest 13F with the SEC ... underperforming the market. We studied the historical stock picks of these investors and our research revealed that the small-cap picks of these funds performed far better ...
INSIDER MONKEY · 4/24/2015
Q: What’s the cheapest hot stock? A: Investors who missed out on 2014’s bull ... These stocks, including miner Freeport-McMoRan (FCX), biotech Gilead Sciences (GILD) and airline Delta Air Lines (DAL), meet a number of strict criteria.
USA TODAY MONEY · ByMatt Krantz · 1/4/2015
Find out below why Procter & Gamble (NYSE: PG), Gilead Sciences (NASDAQ: GILD), and Spectra Energy (NYSE: SE) fit the bill. Selena Maranjian: Proctor & Gamble is an excellent stock for just ... It's no secret that energy stocks have been hit hard ...
USA Today · 7/28/2015
Commences exploration of strategic alternatives for GoTo family of products Gilead Sciences (NASDAQ: GILD) 3% HIGHER ... declared a quarterly cash dividend of $0.07 per share of common stock. The quarterly dividend will be paid on October 1, 2015, to ...
StreetInsider · 7/28/2015
I think the company’s record deserves more respect. A stock I own for almost all my clients is Gilead Sciences Inc. (NASDAQ:GILD). It easily tops my growth criteria with a 26% revenue growth rate and a 27% earnings growth rate for the past five years.
Guru Focus · 7/29/2015
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among …
YCharts · 12/31/2014

Gilead Sciences

Company
Gilead Sciences is an American biotechnology company that discovers, develops and commercializes therapeutics. For many y…
Gilead Sciences is an American biotechnology company that discovers, develops and commercializes therapeutics. For many years since the company was founded, the company concentrated primarily on antiviral drugs to treat patients infected with HIV, hepatitis B, hepatitis C, or influenza. In 2006, Gilead acquired two companies that were developing drugs to treat patients with pulmonary diseases. The company has fourteen commercially available products. Headquartered and founded in Foster City, California, Gilead has operations in North America, Europe and Australia. As of the end of 2009, the company had approximately 4,000 full-time employees. The company's name and logo refer to the Balm of Gilead.
Data from: Wikipedia